Related Experiment Videos
Delayed graft function. Influence on outcome and strategies for prevention
D A Shoskes1, A R Shahed, S Kim
1Departments of Urology and Renal Transplantation, Cleveland Clinic Florida, Weston, Florida, USA. dshoskes@urol.com
Abstract:
Delayed graft function remains a prevalent problem in cadaveric renal transplantation that increases rejection, decreases graft and patient survival, increases the cost of transplantation, and complicates patient management. Although current medical and surgical strategies can reduce the incidence of DGF to 20% or less, newer therapies that focus on nonimmune and immune forms of renal injury are needed to improve outcomes further.
Insights
Delayed graft function (DGF) is a major issue in kidney transplants, impacting survival and costs. New therapies targeting non-immune and immune injury are crucial for improving patient outcomes in renal transplantation.
Area of Science:
- Nephrology
- Transplantation Medicine
- Immunology
Background:
- Delayed graft function (DGF) is a significant complication in cadaveric renal transplantation.
- DGF is associated with increased rejection rates, reduced graft and patient survival, and higher healthcare costs.
- Current management strategies have limitations in fully mitigating DGF incidence and its consequences.
Purpose of the Study:
- To highlight the persistent challenges posed by DGF in renal transplantation.
- To emphasize the need for novel therapeutic approaches beyond existing medical and surgical interventions.
- To underscore the importance of addressing both non-immune and immune-mediated renal injury in DGF.
Main Methods:
- Review of current literature on DGF in renal transplantation.
- Analysis of the impact of DGF on transplant outcomes and patient management.
- Identification of gaps in existing therapeutic strategies for DGF.
Main Results:
- DGF remains a prevalent problem despite current medical and surgical strategies.
- Existing therapies can reduce DGF incidence to approximately 20% but do not eliminate it.
- Further research is needed to develop advanced therapies for DGF.
Conclusions:
- Novel therapies targeting non-immune and immune renal injury are essential for improving outcomes in renal transplantation.
- Addressing the multifaceted nature of DGF is critical for enhancing graft and patient survival.
- Continued innovation in transplantation medicine is required to overcome DGF challenges.